Five genes identified as prognostic markers for colorectal cancer through the integration of genome-wide association study and expression quantitative trait loci data

References

• Siegel RL, Miller KD, Goding Sauer A et al. Colorectal cancer statistics. CA Cancer J. Clin. 70(3), 145–164 (2020).
   PubMed Web of Science ®Google Scholar
• Lu Y, Kweon SS, Tanikawa C et al. Large-scale genome-wide association study of east Asians identifies loci associated with risk for colorectal cancer. Gastroenterology 156(5), 1455–1466 (2019).
   PubMed Web of Science ®Google Scholar
• Huyghe JR, Bien SA, Harrison TA et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat. Genet. 51(1), 76–87 (2019).
   PubMed Web of Science ®Google Scholar
• Guo X, Lin W, Wen W et al. Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125,478 subjects. Gastroenterology 160(4), 1164–1178 (2021).
   PubMed Web of Science ®Google Scholar
• Schaid DJ, Chen W, Larson NB. From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat. Rev. Genet. 19(8), 491–504 (2018).
   PubMed Web of Science ®Google Scholar
• Nodzak C. Introductory methods for eQTL analyses. Methods Mol. Biol. 2082, 3–14 (2020).
   PubMedGoogle Scholar
• Li L, Zhang X, Zhao H. eQTL. Methods Mol. Biol. 871, 265–279 (2012).
   PubMedGoogle Scholar
• Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA 318(19), 1925–1926 (2017).
   PubMed Web of Science ®Google Scholar
• Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res. Synth. Methods 10(4), 486–496 (2019).
   PubMed Web of Science ®Google Scholar
• Wu Y, Zeng J, Zhang F et al. Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits. Nat. Commun. 9(1), 918 (2018).
   PubMedGoogle Scholar
• Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23(R1), R89–R98 (2014).
   PubMedGoogle Scholar
• Thanassoulis G, O'Donnell CJ. Mendelian randomization: nature's randomized trial in the post-genome era. JAMA 301(22), 2386–2388 (2009).
   PubMed Web of Science ®Google Scholar
• Burgess S, Timpson NJ, Ebrahim S et al. Mendelian randomization: where are we now and where are we going? Int. J. Epidemiol. 44(2), 379–388 (2015).
   PubMed Web of Science ®Google Scholar
• Zhu Z, Zhang F, Hu H et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48(5), 481–487 (2016).
   PubMed Web of Science ®Google Scholar
• Ishigaki K, Akiyama M, Kanai M et al. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nat. Genet. 52(7), 669–679 (2020).
   PubMed Web of Science ®Google Scholar
• Lloyd-Jones LR, Holloway A, McRae A et al. The genetic architecture of gene expression in peripheral blood. Am. J. Hum. Genet. 100(2), 228–237 (2017).
   PubMed Web of Science ®Google Scholar
• GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369(6509), 1318–1330 (2020).
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10(1), 1523 (2019).
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45(W1), W98–W102 (2017).
   PubMed Web of Science ®Google Scholar
• Tomczak K, Czerwińska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp. Oncol. (Pozn.) 19(1A), A68–A77 (2015).
   PubMedGoogle Scholar
• Wei J, Huang K, Chen Z et al. Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data. Cancer (Basel). 12(7), 1788 (2020).
   PubMed Web of Science ®Google Scholar
• Bruntz RC, Lindsley CW, Brown HA. Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer. Pharmacol. Rev. 66(4), 1033–1079 (2014).
   PubMed Web of Science ®Google Scholar
• Wagner N, Wagner KD. The role of PPARs in disease. Cells 9(11), 2367 (2020).
   PubMed Web of Science ®Google Scholar
• Currie E, Schulze A, Zechner R et al. Cellular fatty acid metabolism and cancer. Cell Metab. 18(2), 153–161 (2013).
   PubMed Web of Science ®Google Scholar
• Wan Q, Tang J, Han Y et al. Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma. Exp. Eye Res. 166, 13–20 (2018).
   PubMed Web of Science ®Google Scholar
• Bousquet M, Nguyen D, Chen C et al. MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA. Haematologica 97(11), 1713–1721 (2012).
   PubMed Web of Science ®Google Scholar
• Li Y, Wang H, Pan Y et al. Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer. Front Endocrinol. (Lausanne) 14, 1125299 (2023).
   PubMed Web of Science ®Google Scholar
• Li F, Chen L, Zheng J et al. Mechanism of Gegen Qinlian decoction regulating ABTB1 expression in colorectal cancer metastasis based on PI3K/AKT/FOXO1 pathway. Biomed. Res. Int. 2022, 8131531 (2022).
   PubMed Web of Science ®Google Scholar
• Huang L, Zhang Y, Li Z et al. MiR-4319 suppresses colorectal cancer progression by targeting ABTB1. United European Gastroenterol. J. 7(4), 517–528 (2019).
   PubMed Web of Science ®Google Scholar
• Simonetti L, Bruque CD, Fernández CS et al. CYP21A2 mutation update: comprehensive analysis of databases and published genetic variants. Hum. Mutat. 39(1), 5–22 (2018).
   PubMed Web of Science ®Google Scholar
• Guo Y, Rehati A, Wu Z et al. A novel function of CYP21A2 in regulating cell migration and invasion via Wnt signaling. Gen. Physiol. Biophys. 39(4), 373–381 (2020).
   PubMed Web of Science ®Google Scholar
• Yuan Z, Li Y, Zhang S et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol. Cancer 22(1), 48 (2023).
   PubMed Web of Science ®Google Scholar
• Eble JA, Niland S. The extracellular matrix in tumor progression and metastasis. Clin. Exp. Metastasis 36(3), 171–198 (2019).
   PubMed Web of Science ®Google Scholar
• Tryggvason K, Höyhtyä M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim. Biophys. Acta 907(3), 191–217 (1987).
   PubMedGoogle Scholar
• Brabletz T, Kalluri R, Nieto MA et al. EMT in cancer. Nat. Rev. Cancer 18(2), 128–134 (2018).
   PubMed Web of Science ®Google Scholar
• Aiello NM, Kang Y. Context-dependent EMT programs in cancer metastasis. J. Exp. Med. 216(5), 1016–1026 (2019).
   PubMed Web of Science ®Google Scholar
• Gugnoni M, Sancisi V, Gandolfi G et al. Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy. Oncogene 36(5), 667–677 (2017).
   PubMed Web of Science ®Google Scholar
• Cao ZQ, Wang Z, Leng P. Aberrant N-cadherin expression in cancer. Biomed. Pharmacother. 118, 109320 (2019).
   PubMed Web of Science ®Google Scholar
• Ma J, Zhao J, Lu J et al. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT. Tumour Biol. 37(7), 9077–9088 (2016).
   PubMedGoogle Scholar
• Batlle E, Massagué J. Transforming growth factor-β signaling in immunity and cancer. Immunity 50(4), 924–940 (2019).
   PubMed Web of Science ®Google Scholar
• Jung B, Staudacher JJ, Beauchamp D. Transforming growth factor β superfamily signaling in development of colorectal cancer. Gastroenterology 152(1), 36–52 (2017).
   PubMed Web of Science ®Google Scholar
• Zhong FL, Mamaï O, Sborgi L et al. Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation. Cell 167(1), 187–202.e17 (2016).
   PubMed Web of Science ®Google Scholar
• Bauernfried S, Scherr MJ, Pichlmair A et al. Human NLRP1 is a sensor for double-stranded RNA. Science 371(6528), eabd0811 (2021).
   PubMed Web of Science ®Google Scholar
• Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol. Rev. 265(1), 6–21 (2015).
   PubMed Web of Science ®Google Scholar
• Barnett KC, Li S, Liang K et al. A 360° view of the inflammasome: mechanisms of activation, cell death, and diseases. Cell 186(11), 2288–2312 (2023).
   PubMed Web of Science ®Google Scholar
• Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nat. Immunol. 22(5), 550–559 (2021).
   PubMed Web of Science ®Google Scholar
• Karki R, Man SM, Kanneganti TD. Inflammasomes and cancer. Cancer Immunol. Res. 5(2), 94–99 (2017).
   PubMed Web of Science ®Google Scholar
• Shen E, Han Y, Cai C et al. Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients. Aging (Albany NY) 13(5), 7570–7588 (2021).
   PubMedGoogle Scholar
• Dey Sarkar R, Sinha S, Biswas N. Manipulation of inflammasome: a promising approach towards immunotherapy of lung cancer. Int. Rev. Immunol. 40(3), 171–182 (2021).
   PubMed Web of Science ®Google Scholar
• Sharma BR, Kanneganti TD. Inflammasome signaling in colorectal cancer. Transl. Res. 252, 45–52 (2023).
   PubMed Web of Science ®Google Scholar
• Liu R, Truax AD, Chen L et al. Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome components. Oncotarget 6(32), 33456–33469 (2015).
   PubMedGoogle Scholar
• Kishnani PS, Goldstein J, Austin SL et al. Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 21(4), 772–789 (2019).
   PubMed Web of Science ®Google Scholar
• Jarrar Y, Zihlif M, Al Bawab AQ et al. Effects of intermittent hypoxia on expression of glucose metabolism genes in MCF7 breast cancer cell line. Curr. Cancer Drug Targets 20(3), 216–222 (2020).
   PubMed Web of Science ®Google Scholar
• Katsuta E, Huyser M, Yan L et al. A prognostic score based on long-term survivor unique transcriptomic signatures predicts patient survival in pancreatic ductal adenocarcinoma. Am. J. Cancer Res. 11(9), 4294–4307 (2021).
   PubMed Web of Science ®Google Scholar
• Peng JM, Lin SH, Yu MC et al. CLIC1 recruits PIP5K1A/C to induce cell-matrix adhesions for tumor metastasis. J. Clin. Invest. 131(1), e133525 (2021).
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang Y, Xiong S et al. Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling. Proc. Natl Acad. Sci. USA 119(45), e2210618119 (2022).
   PubMed Web of Science ®Google Scholar
• Xu W, Wang P, Petri B et al. Integrin-induced PIP5K1C kinase polarization regulates neutrophil polarization, directionality, and in vivo infiltration. Immunity 33(3), 340–350 (2010).
   PubMed Web of Science ®Google Scholar